Internal Medicine · Portland, OR
NPI
1851711972
Since 2014
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
420 NE Mason St
Portland, OR, 97211
Phone (503) 546-9292
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.3M
13,572 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Andrew J Dworkin prescribed most often to Medicare patients was Atorvastatin Calcium, with 804 prescriptions and refills. In total Andrew J Dworkin wrote 13,572 Medicare prescriptions that cost $1.3M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-10-25.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 804 | 818 | 85 | $37K |
| Metoprolol Succinate Generic | 382 | 389 | 44 | $9,876 |
| Omeprazole Generic | 376 | 382 | 42 | $17K |
| Memantine Hcl Generic | 334 | 339 | 36 | $24K |
| Oxycodone Hcl Generic | 330 | 332 | 59 | $8,576 |
| Gabapentin Generic | 321 | 326 | 35 | $9,395 |
| Eliquis Apixaban | 321 | 327 | 41 | $154K |
| Duloxetine Hcl Generic | 305 | 311 | 33 | $18K |
| Tamsulosin Hcl Generic | 300 | 305 | 29 | $12K |
| Levothyroxine Sodium Generic | 298 | 303 | 31 | $6,709 |
| Furosemide Generic | 272 | 276 | 35 | $5,725 |
| Lisinopril Generic | 268 | 273 | 28 | $6,736 |
| Mirtazapine Generic | 256 | 261 | 31 | $8,245 |
| Trazodone Hcl Generic | 233 | 236 | 24 | $5,793 |
| Amlodipine Besylate Generic | 223 | 227 | 21 | $6,739 |
Brand drugs: 1,730 claims; generic drugs: 11,740 claims; opioid claims: 597.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Andrew J Dworkin were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.